NFKB1 and cancer: Real-time PCR analysis revealed that the combination treatment enhanced the expression of GADD45, a gene associated with DNA damage response and cell cycle arrest, while reducing the expression of NF-κB and c-Myc, both involved in promoting cancer cell survival and proliferation [122].